Abbott has received the US Food and Drug Administration (FDA) approval and CE Mark for its Ultreon 3.0 AI-powered coronary imaging platform. The approval enables the integration of automated imaging ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
To better equip doctors with critical information related to blood clots in patients, Abbott created the Ultreon 1.0 Software, the first of its kind. The Ultreon 1.0 Software gives doctors enhanced ...
Sharjah: Al Qassimi Hospital in Sharjah, part of Emirates Health Services (EHS), has announced the launch of the latest coronary angiography programme, Ultreon 3.0, a fourth‑generation, ...
CHENNAI: Kauvery Heart Institute, the centre of excellence in comprehensive cardiac services at Kauvery Hospital – Kovilambakkam, announces the launch of the latest AI-based Ultreon Coronary Imaging ...
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery ...
Earlier this week, Abbott received U.S. FDA clearance and CE Mark for Ultreon 3.0, an AI-powered optical coherence tomography platform that integrates high‑resolution coronary imaging with automated ...
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results